Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
2care4 Generics ApS
APS
Active
Advertising protection
CVR 36960566
Stenhuggervej 12, 6710
Esbjerg V
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2015 · 11 years old
33 employees
www.2care4generics.dk
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
2care4 Generics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
95M
71M
47M
24M
0M
2021: 56M
56M
2021
2022: 76M (+36% vs 2021)
76M
+36%
2022
2023: 73M (-4% vs 2022)
73M
-4%
2023
2024: 58M (-21% vs 2023)
58M
-21%
2024
2025: 52M (-10% vs 2024)
52M
-10%
2025
EBITDA
DKK millions
67M
50M
34M
17M
0M
2021: 41M
41M
2021
2022: 54M (+32% vs 2021)
54M
+32%
2022
2023: 47M (-13% vs 2022)
47M
-13%
2023
2024: 28M (-40% vs 2023)
28M
-40%
2024
2025: 22M (-21% vs 2024)
22M
-21%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
52.415
58.190
73.414
75.691
55.863
Staff expenses
-30.896
-30.346
-26.457
-21.387
-14.423
EBITDA
21.519
27.844
46.957
54.304
41.440
Depreciation & amort.
-5.568
-5.788
-5.797
-9.655
-5.280
EBIT
15.951
22.056
41.160
44.649
36.160
Net financials
-1.636
-51
-678
-377
96
Profit before tax
14.315
22.005
40.482
44.272
36.256
Tax
3.108
4.812
8.918
9.674
7.174
Net profit
11.207
17.193
31.564
34.598
29.083
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
115.193
129.738
170.370
170.991
127.774
Equity
49.944
78.737
86.544
74.230
44.632
Long-term debt
0
0
350
356
0
Short-term debt
51.842
40.878
74.806
87.742
74.974
Total debt
51.842
40.878
75.156
88.098
74.974
Financial ratios
5-year trend
EBITDA margin (of gross profit)
41,1 %
This company
2021
2025
Equity ratio
43,4 %
This company
38,2 %
Market median
This company
Market median
14% above market
2021
2025
Return on equity
22,4 %
This company
18,4 %
Market median
This company
Market median
22% above market
2021
2025
Net profit margin (of gross profit)
21,4 %
This company
2021
2025
Asset turnover (of gross profit)
0,46×
This company
2021
2025
Debt / equity
1,31×
This company
0,62×
Market median
This company
Market median
111% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on 2care4 Generics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network